SCHEMBL19692983

SCHEMBL19692983

CO[C@@H]1[C@H](O[Si](C)(C)C(C)(C)C)[C@@H](/C=C/P(O)(O)=S)O[C@H]1n1c(=O)cc[nH]c1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2565975 0.85 — —
SCHEMBL19693019 0.79 — —
SCHEMBL29492489 0.70 P2RY2 (0.40) —
SCHEMBL29607435 0.69 DUT (0.40) —
SCHEMBL19709266 0.69 DUT (0.40) —
SCHEMBL19709264 0.69 DUT (0.40) —
SCHEMBL17144041 0.66 DUT (0.33) —
SCHEMBL31543054 0.65 — —
SCHEMBL23313171 0.65 P2RY2 (0.44) —
SCHEMBL20820770 0.64 P2RY2 (0.40) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3464313-A1 5'-CYCLO-PHOSPHONATE MODIFIED NUCLEOTIDES Arrowhead Pharmaceuticals, Inc. (US) 2019-04-10 — — EP disclosed
WO-2017214112-A1 5'-CYCLO-PHOSPHONATE MODIFIED NUCLEOTIDES Arrowhead Pharmaceuticals, Inc. (US) 2017-12-14 — — WO disclosed
Send feedback